Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 1
2015 1
2018 1
2019 1
2020 1
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
[Art, health and prevention: initial collaborations].
Avila N, Orellana A, Cano MG, Antúnez N, Claver D. Avila N, et al. Among authors: cano mg. Gac Sanit. 2014 Nov-Dec;28(6):501-4. doi: 10.1016/j.gaceta.2014.07.002. Epub 2014 Aug 23. Gac Sanit. 2014. PMID: 25156001 Free article. Spanish.
Allergy to pumpkin with cyclophilin as the relevant allergen.
González De Olano D, González-Mancebo E, Macadán SS, Cano MG, Pérez-Gordo M, Ortega BC, Vivanco F, Vargas CP. González De Olano D, et al. Among authors: cano mg. Ann Allergy Asthma Immunol. 2010 Jan;104(1):98-9. doi: 10.1016/j.anai.2009.11.019. Ann Allergy Asthma Immunol. 2010. PMID: 20143656 No abstract available.
Anxiety, Depression, and Asthma Control: Changes After Standardized Treatment.
Sastre J, Crespo A, Fernandez-Sanchez A, Rial M, Plaza V; investigators of the CONCORD Study Group. Sastre J, et al. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):1953-1959. doi: 10.1016/j.jaip.2018.02.002. Epub 2018 Feb 15. J Allergy Clin Immunol Pract. 2018. PMID: 29454162
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, Mallik S, Zajicek J. Ball S, et al. Among authors: cano mg. Health Technol Assess. 2015 Feb;19(12):vii-viii, xxv-xxxi, 1-187. doi: 10.3310/hta19120. Health Technol Assess. 2015. PMID: 25676540 Free PMC article. Clinical Trial.